EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis

Henry C Skrehot, Dario J Englot, Zulfi Haneef

Epilepsy & Behavior · 2023-05 · 142 · 109182

DOI: 10.1016/j.yebeh.2023.109182 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Epilepsy & Behavior, 2023-05. Verfasst von Henry C Skrehot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Epilepsies, Partial, Drug Resistant Epilepsy, Vagus Nerve Stimulation. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Different neurostimulation modalities are available to treat drug-resistant focal epilepsy when surgery is not an option including vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS). Head-to-head comparisons of efficacy do not exist between them nor are likely to be available in the future. We performed a meta-analysis on VNS, RNS, and DBS outcomes to compare seizure reduction efficacy for focal epilepsy. METHODS: We systematically reviewed the literature for reported seizure outcomes following implantation with VNS, RNS, and DBS in focal-onset seizures and performed a meta-analysis. Prospective or retrospective clinical studies were included. RESULTS: Sufficient data were available at years one (n = 642, two (n = 480), and three (n = 385) for comparing the three modalities with each other. Seizure reduction for the devices at years one, two, and three respectively were: RNS: 66.3%, 56.0%, 68.4%; DBS- 58.4%, 57.5%, 63.8%; VNS 32.9%, 44.4%, 53.5%. Seizure reduction at year one was greater for RNS (p < 0.01) and DBS (p < 0.01) compared to VNS. CONCLUSIONS: Our findings indicate the seizure reduction efficacy of RNS is similar to DBS, and both had greater seizure reductions compared to VNS in the first-year post-implantation, with the differences diminishing with longer-term follow-up. SIGNIFICANCE: The results help guide neuromodulation treatment in eligible patients with drug-resistant focal epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationEpilepsies, PartialDrug Resistant EpilepsyVagus Nerve StimulationHumansRetrospective StudiesProspective StudiesSeizuresTreatment Outcome

Stichwörter der Autor:innen

DBSFocal EpilepsyMeta-analysisNeurostimulationRNSVNS

Autor:innen und Institutionen

  • Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Departments of Neurological Surgery, Neurology, Radiology, Electrical Engineering, and Biomedical Engineering, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA; Neurology Care Line, VA Medical Center, Houston, TX 77030, USA. Electronic address: zulfi.haneef@bcm.edu.

Zitieren

APA

Skrehot, H. C., Englot, D. J., & Haneef, Z. (2023). Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis. Epilepsy & Behavior, 142, 109182. https://doi.org/10.1016/j.yebeh.2023.109182

Vancouver

Skrehot HC, Englot DJ, Haneef Z. Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis. Epilepsy & Behavior. 2023;142:109182. doi:10.1016/j.yebeh.2023.109182

BibTeX
@article{Skrehot2023,
  author = {Skrehot, Henry C and Englot, Dario J and Haneef, Zulfi},
  title = {Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis},
  journal = {Epilepsy & Behavior},
  year = {2023},
  volume = {142},
  pages = {109182},
  doi = {10.1016/j.yebeh.2023.109182}
}
Kostenlos starten →